MEDOF(MEDOF)
MEDOF
No analyst ratings available
No analyst price targets available for MEDOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.11B | $2.20B | $2.35B |
| Low | $2.04B | $2.11B | $2.27B |
| High | $2.17B | $2.29B | $2.43B |
| EBITDA Avg | $87M | $92M | — |
| Low | $85M | $89M | — |
| High | $89M | $94M | — |
| EBIT Avg | $55M | $64M | — |
| Low | $52M | $62M | — |
| High | $57M | $67M | — |
| Net Income Avg | $35M | $42M | — |
| Low | $33M | $40M | — |
| High | $36M | $44M | — |
| EPS Avg | $1.38 | $1.69 | — |
| Low | $1.32 | $1.61 | — |
| High | $1.44 | $1.77 | — |
| Analysts (Rev / EPS) | 3 / 1 | 4 / 1 | 1 / — |